Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX)

CUSIP: 695127100

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
-366,822
Put/Call ratio
234%
SEC-reported price per share
$60.12
Number of holders
255
Value change
-$13,442,917
Number of buys
128
Open additional details 1 more signal available
Number of sells
116
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
39,614,942

Security key

695127100

Report period

Q3 2020

Institutions

255

Top holders

10

Ownership snapshot

Top reported holders of PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $368,443,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $368.44M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $368.44M
VANGUARD GROUP INC $229.61M
RENAISSANCE TECHNOLOGIES LLC $149.58M
MACQUARIE GROUP LTD $106.29M
DEERFIELD MANAGEMENT COMPANY, L.P. $87.26M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$368,443,000
7,021,974 shares
— 30 Jun 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$229,609,000
4,375,979 shares
— 30 Jun 2020
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$149,581,000
2,850,797 shares
— 30 Jun 2020
MACQUARIE GROUP LTD
13F
Company
13F
—
denominator unverified
$106,293,000
2,025,772 shares
— 30 Jun 2020
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$87,258,000
1,663,000 shares
— 30 Jun 2020
Spyglass Capital Management LLC
13F
Company
13F
—
denominator unverified
$80,323,000
1,530,831 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
255
Shares
48,261,472
Rows available
255
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
241
Q3 2020 holders
255
Holder diff
14
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .